Endothelial Dysfunction May Link Interatrial Septal Abnormalities and MTHFR-Inherited Defects to Cryptogenic Stroke...

Area of Science:

• Cardiovascular Research
• Genetics
• Biomarker Discovery

Background:

• Endothelial dysfunction is a key factor in stroke pathogenesis.
• The L-Arginine/asymmetric dimethylarginine (L-Arg/ADMA) ratio reflects endothelial function.
• Interatrial septum (IAS) phenotypes and MTHFR genotype are associated with stroke risk.

Purpose of the Study:

• To investigate the L-Arg/ADMA ratio as a biomarker for endothelial dysfunction in stroke patients.
• To evaluate the correlation between the L-Arg/ADMA ratio, MTHFR genotype, and IAS phenotype severity.
• To explore the potential of the L-Arg/ADMA ratio in predicting stroke susceptibility.

Main Methods:

• Measured L-Arg, ADMA, and MTHFR genotypes in 57 stroke patients.
• Assessed IAS phenotypes (septum integrum, patent foramen ovale, ostium secundum) using transesophageal echocardiography.
• Correlated L-Arg/ADMA ratio with IAS severity and MTHFR genotype variations.

Main Results:

• The L-Arg/ADMA ratio significantly differed across IAS phenotypes, being higher in septum integrum patients.
• A negative correlation was observed between the L-Arg/ADMA ratio and patent foramen ovale tunnel dimensions.
• L-Arg/ADMA ratios were lower in patients with more impaired MTHFR genotypes, particularly in ostium secundum subgroups.

Conclusions:

• A low L-Arg/ADMA ratio is linked to impaired MTHFR activity and specific IAS phenotypes, suggesting a role in endothelial dysfunction-related stroke.
• Genetic MTHFR defects may contribute to IAS abnormalities and increase susceptibility to cryptogenic stroke.
• The L-Arg/ADMA ratio serves as a valuable marker for stroke risk in individuals with IAS abnormalities, aiding diagnosis and treatment decisions.